Dr. Quinn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
# ML7015
Cincinnati, OH 45229Phone+1 513-636-4266Fax+1 513-636-3549
Education & Training
- UT Southwestern Medical CenterMS, Clinical Sciences, 2005 - 2008
- University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 1998 - 2001
- University of Texas Southwestern Medical CenterChief Residency, Pediatrics, 1998
- University of Texas Southwestern Medical SchoolClass of 1994
- Texas Christian UniversityBS, Biology, Magna cum laude, 1986 - 1990
Certifications & Licensure
- OH State Medical License 2010 - 2026
- IN State Medical License 2021 - 2025
- KY State Medical License 2022 - 2025
- TX State Medical License 1996 - 2024
- FL State Medical License 2015 - 2017
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top Doctor U.S. News and World Report, 2011
- Dean’s Scholar in Clinical Science 2005
- Join now to see all
Clinical Trials
- Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease Start of enrollment: 2012 Aug 16
- Losartan to Reverse Sickle Nephropathy Start of enrollment: 2012 Feb 01
- A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 88 citationsCardiomyopathy With Restrictive Physiology in Sickle Cell DiseaseOmar Niss, Charles T. Quinn, Adam Lane, Joshua A. Daily, Philip R. Khoury
JACC. Cardiovascular Imaging. 2016-03-01 - 51 citationsRisk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical R...Claudia R. Morris, Hae-Young Kim, Felicia Trachtenberg, John C. Wood, Charles T. Quinn
Blood. 2011-10-06 - 6 citationsAutomated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia.Alina Sadaf, Katie G. Seu, Elizabeth Thaman, Rose Fessler, Diamantis G. Konstantinidis
Frontiers in Physiology. 2021-03-25
Journal Articles
- L-glutamine for Sickle Cell Anemia: More Questions Than AnswersCharles Quinn, MD, Blood
- Yet another mechanism of action for hydroxyurea in sickle cell disease?Quinn CT, The Hematologist: ASH News and Reports, 7/1/2014
- Lessons from the liver: rebalanced hemostasis in immune thrombocytopenia (ITP)Quinn CT, The Hematologist: ASH News and Reports, 5/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- An Immersive Virtual Reality Curriculum for Pediatric Providers on Shared Decision Making for HydroxyureaCharles T. Quinn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Feasibility of Electronic Monitoring of Daily Oral Medications in Adolescents with Sickle Cell DiseaseCharles T. Quinn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal StudyCharles T. Quinn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Evaluation of Phenotype-Genotype Correlation in Two Common PIEZO1 Mutations p.R2456H and p.L2495_E2495dup2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- “Sickle cell disease: a tale of survival”.Memphis, TN - 4/1/2014
- “Hemolytic Anemia"New Orleans, LA - 12/1/2013
- Join now to see all
Other
- Sickle cell disease in children and adolescents: diagnosis, guidelines for comprehensive care, and care paths and protocols for management of acute and chronic complic...Lane PA, Buchanan GR, Hutter JJ, Austin RF, Britton HA, Rogers ZR, Eckman JR, DeBaun MR, Wang WC, Mathew P, Iden S, Recht M, Cohen JD, Frugé E, Embry L, Hsu L, Mueller...
http://scinfo.org/care-paths-and-protocols-children-adolescents/
11/1/2001
Press Mentions
- Does Our Healthcare System Abandon Adult Sickle Cell Patients?March 22nd, 2016
Grant Support
- A Controlled Clinical Trial of Regadenoson in Sickle Cell AnemiaNational Institutes of Health (NHLBI)2012–Present
- Hydroxyurea to prevent CNS complications of sickle cell disease in children.National Institutes of Health2011–2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: